Alterations in PD-L1&lt;sup&gt;+&lt;/sup&gt; Myeloid Cells and Immune Infiltration Are Associated with Atezolizumab and Paclitaxel Therapy Success in a Triple-Negative Breast Cancer Model. The gene discussed is CD274; the disease is breast carcinoma.